855-31978-05791
4 vaccinations
10 coded responses
35 check-ins
10 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 957 / CA
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Pfizer-BioNTech
-
2021-02-10
Dose 2 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-05-12
- 2021-08-11
-
2021-08-17
Dose 3 — Pfizer-BioNTech
- 2021-08-17
-
2021-08-18
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-08-19
Survey response — days 1–6 daily, dose 3MedDRA: Injected limb mobility decreased, Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lymph nodes under shot arm have been extremely painful and swollen. Better today, but still limited use of arm.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-20
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy, Parosmia, Taste disorder — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pain still moderate in shot arm lymph node area and swollen. Not nauseous but still many usual foods smell bad or are unappetizing.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, SwellingFree text: Swelling in lymph nodes in armpit of shot stem still thereMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-23
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NaMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-24
- 2021-08-31
- 2021-09-07
- 2021-09-14
-
2021-09-21
Survey response — day 35, dose 3MedDRA: Joint effusion — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: R knee effusionMedDRA releases: 2024-11 · check-in free text available
-
2021-09-21
Report sent to call center — day 35, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-09-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2021-09-28
- 2021-11-16
-
2022-02-15
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activitiesFree text: OmnicronMedDRA releases: 2024-11 · check-in free text available
-
2022-05-26
Dose 4 — Moderna
-
2022-05-27
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-05-28
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-05-29
Survey response — days 1–6 daily, dose 4MedDRA: Dyspnoea — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Forgot to mention difficulty with breathing- O2 running 86-88MedDRA releases: 2024-11 · check-in free text available
-
2022-05-30
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-05-31
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-06-01
- 2022-06-02
- 2022-06-09
- 2022-06-16
- 2022-06-23
-
2022-06-30
Survey response — day 35, dose 4MedDRA: COVID-19, Eye pain, Ocular hyperaemia, Office visit, Respiratory disorder, Vision blurred — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Eye redness, blurring, pain. Breathing isn't like it was before I got Covid · Healthcare visit (other): Walk inMedDRA releases: 2024-11 · check-in free text available
-
2022-06-30
Report sent to call center — day 35, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-07-01
- 2022-07-01
-
2022-07-01
Call successfulParticipant prefers to complete VAERS report online
- 2022-07-07
-
2022-08-25
Survey response — 3 months, dose 4MedDRA: Blood pressure increased, Cardiac failure congestive, Hypoxia, Renal disorder — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Congestive heart failure, mild kidney difficulties, hypoxia, high BPMedDRA releases: 2024-11 · check-in free text available
-
2022-08-25
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-08-26
-
2022-08-26
Call successfulDoes not wish to fill out VAERS report
-
2022-11-24
Survey response — 6 months, dose 4MedDRA: Cardiac failure, Pulmonary arterial hypertension — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Pulmonary arterial hypertension and heart failureMedDRA releases: 2024-11 · check-in free text available
-
2022-11-24
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-11-25
- 2023-05-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Pfizer-BioNTech | |
| 2 | 2021-02-10 | Pfizer-BioNTech | |
| 3 | 2021-08-17 | Pfizer-BioNTech | No |
| 4 | 2022-05-26 | Moderna | No |
Call center
4 call center cases
3 successful · 1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Lymph nodes under shot arm have been extremely painful and swollen. Better today, but still limited use of arm.
Systemic reaction (other): Pain still moderate in shot arm lymph node area and swollen. Not nauseous but still many usual foods smell bad or are unappetizing.
Systemic reaction (other): Swelling in lymph nodes in armpit of shot stem still there
Systemic reaction (other): Na
Release 9 — day 35, dose 3
Symptoms: R knee effusion
Release 11 — 6 months, dose 3
Symptoms: Omnicron
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Forgot to mention difficulty with breathing- O2 running 86-88
Release 12 — day 35, dose 4
Symptoms: Eye redness, blurring, pain. Breathing isn't like it was before I got Covid
Healthcare visit (other): Walk in
Release 12 — 3 months, dose 4
Symptoms: Congestive heart failure, mild kidney difficulties, hypoxia, high BP
Release 12 — 6 months, dose 4
Symptoms: Pulmonary arterial hypertension and heart failure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Cardiac failure | · | · | ✓ |
| SD | Cardiac failure congestive | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Eye pain | · | · | ✓ |
| SD | Hypoxia | · | · | ✓ |
| SD | Joint effusion | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SD | Pulmonary arterial hypertension | · | · | ✓ |
| SD | Renal disorder | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Injected limb mobility decreased | ✓ | · | ✓ |
| SRO | Lymph node pain | ✓ | · | ✓ |
| SRO | Lymphadenopathy | ✓ | · | ✓ |
| SRO | No adverse event | ✓ | · | ✓ |
| SRO | Parosmia | ✓ | · | ✓ |
| SRO | Taste disorder | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release